A holding company building a global integrated AI-driven healthcare ecosystem

Leo International Precision Health AG (LIPH AG) is a holding company building a global integrated AI-driven healthcare ecosystem. With a strategic focus on AI-driven precision healthcare assets across Healthcare Services, MedTech, HealthTech and Biotech, LIPH AG offers investors access to the expanding Asian and global healthcare and life sciences market. The Company is listed in the General Standard at the Frankfurt Stock Exchange (ticker symbol: LEOW).

As LIPH AG continues to connect technology, care, and capital, it aims to deliver sustainable value creation for shareholders while shaping the future of intelligent, data-driven healthcare globally.

LIPH AG's investment case is built on scalability, innovation, and synergy. By placing precision health at the core of its growth strategy and leveraging international capital markets to drive innovation, the Company aims to increase shareholder value through asset reconfiguration, revenue growth, licensing and royalties.

Leo International Precision Health AG (LIPH AG) builds and manages a diversified portfolio of global AI-driven precision-healthcare and life sciences companies advancing innovation diagnostics & medtech, healthtech, personalized care and therapeutics. The portfolio focuses on assets that leverage data and technology to improve medical outcomes, responsively address evolving patient needs, and deliver growth potential.

By reconfiguring and strategically integrating assets, LIPH AG supports its companies in accelerating development, expanding market reach, and creating long-term value for patients, partners and shareholders. LIPH AG aims to create a scalable healthcare platform with strong cash-generating capabilities by driving synergy across its portfolio companies.

Another core element of its strategy is the re-investment of cash flows generated by its established healthcare assets into next-generation biotechnology companies and innovations, with a particular focus on oncology and precision medicine.